Now showing items 1-4 of 4

    • Competing risks to breast cancer mortality in Catalonia 

      Vilaprinyo Terré, Ester; Gispert i Magarolas, Rosa; Martínez Alonso, Montserrat; Carles Lavila, Misericordia; Pla, Roger; Espinàs, Josep Alfons; Rué i Monné, Montserrat (BioMed Central, 2008)
      Background: Breast cancer mortality has experienced important changes over the last century. Breast cancer occurs in the presence of other competing risks which can influence breast cancer incidence and mortality trends. ...
    • Dissemination of periodic mammography and patterns of use, by birth cohort, in Catalonia (Spain) 

      Rué i Monné, Montserrat; Carles Lavila, Misericordia; Vilaprinyo Terré, Ester; Martínez Alonso, Montserrat; Espinàs, Josep Alfons; Pla, Roger; Brugulat, Pilar (BioMed Central, 2008)
      Background: In Catalonia (Spain) breast cancer mortality has declined since the beginning of the 1990s. The dissemination of early detection by mammography and the introduction of adjuvant treatments are among the possible ...
    • Effectiveness of early detection on breast cancer mortality reduction in Catalonia (Spain) 

      Rué i Monné, Montserrat; Vilaprinyo Terré, Ester; Lee, Sandra; Martínez Alonso, Montserrat; Carles Lavila, Misericordia; Marcos-Gragera, Rafael; Pla, Roger; Espinàs, Josep Alfons (BioMed Central, 2009)
      Background: At present, it is complicated to use screening trials to determine the optimal age intervals and periodicities of breast cancer early detection. Mathematical models are an alternative that has been widely used. ...
    • The effect of information about the benefits and harms of mammography on women’s decision-making: study protocol for a randomized controlled trial 

      Misericòrdia, Carles; Martínez Alonso, Montserrat; Pons Rodríguez, Anna; Pérez Lacasta, María José; Perestelo Pérez, Lilisbeth; Sala, Maria; Vidal, Carmen; Garcia, Montse; Toledo Chávarri, Ana; Codern, Núria; Feijoo Cid, Maria; Romero, Anabel; Pla, Roger; Soler González, Jorge; Castells, Xavier; Rué i Monné, Montserrat (BioMed Central, 2017)
      The decision to participate or not in breast cancer screening is complex due to the trade-off between the expected benefit of breast cancer mortality reduction and the major harm of overdiagnosis. It seems ethically necessary ...